https://orcid.org/0000-0003-3314-2411
Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Alessio Nocentini, Clemente Capasso & Claudiu T. Supuran. (2022) Perspectives on the design and discovery of α-ketoamide inhibitors for the treatment of novel coronavirus: where do we stand and where do we go?. Expert Opinion on Drug Discovery 17:6, pages 547-557.
Read now
Read now
Claudiu T. Supuran. (2021) Coronaviruses. Expert Opinion on Therapeutic Patents 31:4, pages 291-294.
Read now
Read now
Matteo Pavan, Giovanni Bolcato, Davide Bassani, Mattia Sturlese & Stefano Moro. (2021) Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1645-1649.
Read now
Read now
Articles from other publishers (12)
Fan Yang, Chenglong Liu, Pengyuan Li, Aihua Wu, Yue Ma-Lauer, Hao Zhang, Zhuang Su, Wei Lu, Albrecht von Brunn & Di Zhu. (2023) Targeting Cyclophilin A and CD147 to Inhibit Replication of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and SARS-CoV-2–Induced Inflammation. Molecular Pharmacology 104:6, pages 239-254.
Crossref
Crossref
Andrea Citarella, Alessandro Dimasi, Davide Moi, Daniele Passarella, Angela Scala, Anna Piperno & Nicola Micale. (2023) Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives. Biomolecules 13:9, pages 1339.
Crossref
Crossref
Helong Feng, Lun Yao, Zhe Zeng, Liren Jiang, Yu Shang, Hongcai Wang, Li Li, Zichen Wang, Xin Wang, Hongchun Yang, Qingqing Zhao, Xiangfei Ren, Tengfei Zhang, Rongrong Zhang, Yunqing Guo, Qin Lu, Qiao Hu, Wenting Zhang, Chan Ding, Huabin Shao, Guofu Cheng, Qingping Luo & Guoyuan Wen. (2023)
Identification of Embryonic Chicken Proteases Activating Newcastle Disease Virus and Their Roles in the Pathogenicity of Virus Used as
In Ovo
Vaccine
. Journal of Virology.
Crossref
Crossref
Zachariah P. Schuurs, John P. McDonald, Laura V. Croft, Derek J. Richard, Roger Woodgate & Neha S. Gandhi. (2023) Integration of molecular modelling and in vitro studies to inhibit LexA proteolysis. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Xinhong Li, Yijie Xu, Wei Li, Jinjing Che, Xu Zhao, Ruyuan Cao, Xingzhou Li & Song Li. (2023) Design, Synthesis, Biological Evaluation, and Molecular Dynamics Simulation of Influenza Polymerase PB2 Inhibitors. Molecules 28:4, pages 1849.
Crossref
Crossref
Vasundara Srinivasan, Hévila Brognaro, Prince R. Prabhu, Edmarcia Elisa de Souza, Sebastian Günther, Patrick Y. A. Reinke, Thomas J. Lane, Helen Ginn, Huijong Han, Wiebke Ewert, Janina Sprenger, Faisal H. M. Koua, Sven Falke, Nadine Werner, Hina Andaleeb, Najeeb Ullah, Bruno Alves Franca, Mengying Wang, Angélica Luana C. Barra, Markus Perbandt, Martin Schwinzer, Christina Schmidt, Lea Brings, Kristina Lorenzen, Robin Schubert, Rafael Rahal Guaragna Machado, Erika Donizette Candido, Danielle Bruna Leal Oliveira, Edison Luiz Durigon, Stephan Niebling, Angelica Struve Garcia, Oleksandr Yefanov, Julia Lieske, Luca Gelisio, Martin Domaracky, Philipp Middendorf, Michael Groessler, Fabian Trost, Marina Galchenkova, Aida Rahmani Mashhour, Sofiane Saouane, Johanna Hakanpää, Markus Wolf, Maria Garcia Alai, Dusan Turk, Arwen R. Pearson, Henry N. Chapman, Winfried Hinrichs, Carsten Wrenger, Alke Meents & Christian Betzel. (2022) Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease. Communications Biology 5:1.
Crossref
Crossref
Haozhou Tan, Yanmei Hu, Prakash Jadhav, Bin Tan & Jun Wang. (2022) Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease. Journal of Medicinal Chemistry 65:11, pages 7561-7580.
Crossref
Crossref
Alexey Komissarov, Maria Karaseva, Marina Roschina, Sergey Kostrov & Ilya Demidyuk. (2022) The SARS-CoV-2 main protease doesn’t induce cell death in human cells in vitro. PLOS ONE 17:5, pages e0266015.
Crossref
Crossref
Kamonpan Sanachai, Panupong Mahalapbutr, Vannajan Sanghiran Lee, Thanyada Rungrotmongkol & Supot Hannongbua. (2021)
In Silico
Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease
. The Journal of Physical Chemistry B 125:50, pages 13644-13656.
Crossref
Crossref
Sakine Kübra ÇELİK & Elvan ÜSTÜN. (2021) Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2Cistus incanus’un Bazı Biyoaktif Moleküllerinin SARS CoV-2 ye Karşı Moleküler Doking Analizi. Karadeniz Fen Bilimleri Dergisi 11:2, pages 522-532.
Crossref
Crossref
David A. Davis, Haydar Bulut, Prabha Shrestha, Amulya Yaparla, Hannah K. Jaeger, Shin-ichiro Hattori, Paul T. Wingfield, John J. Mieyal, Hiroaki Mitsuya & Robert Yarchoan. (2021) Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300. mBio 12:4.
Crossref
Crossref
Mohd. Imran, Ahmed Subeh Alshrari, Syed Mohammed Basheeruddin Asdaq & Abida. (2021) Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review. Journal of Infection and Public Health 14:8, pages 1075-1086.
Crossref
Crossref